Pulmonary eosinophilia with systemic features: therapy and prognosis

Area of Science:

• Pulmonology
• Rheumatology
• Immunology

Background:

• Pulmonary eosinophilia can present with or without systemic manifestations.
• Identifying systemic features is crucial for diagnosis and management.
• Cryptogenic pulmonary eosinophilia and Churg Strauss syndrome are potential diagnoses.

Purpose of the Study:

• To investigate the clinical characteristics and outcomes of patients with pulmonary eosinophilia and systemic features.
• To compare these patients with those having isolated pulmonary eosinophilia.
• To evaluate the efficacy of treatment in this cohort.

Main Methods:

• Retrospective analysis of 65 patients with pulmonary eosinophilia over 20 years.
• Detailed review of clinical features, laboratory findings, and treatment responses.
• Classification of patients based on systemic involvement and specific diagnoses (cryptogenic vs. Churg Strauss syndrome).

Main Results:

• 18% of patients exhibited systemic features including fever, night sweats, arthralgia, rashes, and weight loss.
• Patients with systemic features had higher eosinophil counts and less frequent asthma or recurrent eosinophilia.
• Steroid therapy led to good clinical and radiological responses in most patients, with sustained lung function.

Conclusions:

• Pulmonary eosinophilia with systemic features represents a distinct clinical entity.
• Early recognition and treatment with corticosteroids are effective, leading to favorable long-term outcomes.
• Systemic involvement does not preclude a good prognosis with appropriate management.